↓ Skip to main content

Cannabinoids and Neuropsychiatric Disorders

Overview of attention for book
Attention for Chapter: Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
5 news outlets
twitter
10 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
95 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Cannabidiol Therapy for Refractory Epilepsy and Seizure Disorders
Book title
Cannabinoids and Neuropsychiatric Disorders
Published in
Advances in experimental medicine and biology, December 2020
DOI 10.1007/978-3-030-57369-0_7
Pubmed ID
Book ISBNs
978-3-03-057368-3, 978-3-03-057369-0
Authors

Victoria Golub, D. Samba Reddy, Golub, Victoria, Reddy, D. Samba

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 95 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 95 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 13%
Student > Ph. D. Student 11 12%
Student > Bachelor 9 9%
Student > Master 6 6%
Other 4 4%
Other 10 11%
Unknown 43 45%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 14 15%
Neuroscience 9 9%
Medicine and Dentistry 9 9%
Biochemistry, Genetics and Molecular Biology 5 5%
Agricultural and Biological Sciences 3 3%
Other 10 11%
Unknown 45 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 47. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 June 2023.
All research outputs
#844,051
of 24,417,958 outputs
Outputs from Advances in experimental medicine and biology
#97
of 5,197 outputs
Outputs of similar age
#23,583
of 511,550 outputs
Outputs of similar age from Advances in experimental medicine and biology
#4
of 58 outputs
Altmetric has tracked 24,417,958 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,197 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 511,550 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.